Barnhart K T, Sondheimer S J
Division of Human Reproduction, Hospital of The University of Pennsylvania, Philadelphia.
Curr Opin Obstet Gynecol. 1993 Dec;5(6):823-8.
Sexually active couples need to be concerned with the risk of sexually transmitted diseases (STDs) and how their choice of contraception influences that risk. Condoms provide the best documented protection against such pathogens as: gonorrhea, herpes simplex virus (HSV), hepatitis B, HIV, and chlamydia. Female dependent barrier methods also provide protection against most STDs and also possibly HIV. Most hormonal non-barrier contraceptives, although providing excellent protection against unwanted pregnancies, provide little protection against STDs. Oral contraceptive pills (OCP) may increase the risk of infection with human papillomavirus (HPV) and cervical infections of chlamydia. Individuals at high risk for both an unwanted pregnancy and an STD should be counseled to use both a hormonal and barrier contraceptive. Recently, nonoxynol-9 (N-9) and OCP use have been associated with an increase in HIV infection in African women at high risk for HIV. This association has not been found in other studies and currently does not outweigh the proven benefits of these contraceptive methods.
性活跃的伴侣需要关注性传播疾病(STD)的风险,以及他们选择的避孕方式如何影响这种风险。避孕套对淋病、单纯疱疹病毒(HSV)、乙型肝炎、艾滋病毒和衣原体等病原体提供了有充分记录的最佳防护。女性专用屏障避孕法也能预防大多数性传播疾病,还可能预防艾滋病毒。大多数非屏障激素避孕法虽然能有效防止意外怀孕,但对性传播疾病几乎没有防护作用。口服避孕药(OCP)可能会增加感染人乳头瘤病毒(HPV)和衣原体宫颈感染的风险。对于意外怀孕和性传播疾病风险都高的个体,应建议其同时使用激素避孕法和屏障避孕法。最近,壬苯醇醚-9(N-9)和口服避孕药的使用与感染艾滋病毒风险高的非洲女性感染艾滋病毒的增加有关。其他研究未发现这种关联,目前这种关联也没有超过这些避孕方法已证实的益处。